Particle.news
Download on the App Store
20 ARTICLES
·
3w ago

FDA Vaccine Chief Resigns, Citing RFK Jr.'s Vaccine Misinformation

Peter Marks' resignation raises concerns over public health, regulatory stability, and the biotech sector under the Trump administration.

A top FDA regulator resigned Friday, citing Robert F. Kennedy's persistent spread of vaccine misinformation.
Image
Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration gives an opening statement during a Senate Health, Education, Labor and Pensions Committee hearing to discuss the on-going federal response to COVID-19, at the U.S. Capitol in Washington, D.C., U.S., May 11, 2021. Greg Nash/Pool via REUTERS
Director Center for Biologics Evaluation and Research, at the US Food and Drug Administration, Peter Marks, testifies during a Senate Health, Education, Labor and Pensions Committee hearing on the federal coronavirus response on Capitol Hill in Washington, DC, March 18, 2021. (Photo by Susan Walsh / POOL / AFP) (Photo by SUSAN WALSH/POOL/AFP via Getty Images)

Overview

  • Peter Marks, the FDA's top vaccine regulator, resigned effective April 5, citing fundamental disagreements with HHS Secretary Robert F. Kennedy Jr.'s vaccine skepticism and misinformation.
  • Marks' departure has triggered significant declines in biotech and vaccine stock prices, with companies like Moderna and Novavax experiencing double-digit losses.
  • In his resignation letter, Marks criticized the erosion of scientific standards and the undermining of public confidence in vaccines, warning of serious risks to public health.
  • The resignation is part of broader restructuring at HHS under Kennedy, including 3,500 job cuts at the FDA, fueling concerns about regulatory instability and slowed drug approvals.
  • Public health experts and industry leaders have expressed alarm, viewing Marks' exit as a major loss for scientific leadership and innovation at the FDA.